Cadence Neuroscience
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8201 164th Ave NE Ste 330, Redmond, Wash...Phone Number
(425) 298-3184Website
www.cadenceneuro.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Cadence Neuroscience
Cadence Neuroscience develops new medical device therapies for the treatment of epilepsy and other neurological disorders. The company was founded in 2017 and is headquartered in Redmond, Washington.Explore more
Cadence Neuroscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cadence Neuroscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cadence Neuroscience
Cadence Neuroscience, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Cadence Neuroscience has new funding data
Product Launch: Get notified when Cadence Neuroscience launches new products
Check out if Cadence Neuroscience is spiking on competitors!
Click to see if Cadence Neuroscience had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Cadence Neuroscience recently announced quarterly report
Check if Cadence Neuroscience has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Cadence Neuroscience
Find 3 more new buyers
Compare Similar Companies to Cadence Neuroscience
Compare insights from companies similar to Cadence Neuroscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cadence Neuroscience is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cadence Neuroscience is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cadence Neuroscience.
Cadence Neuroscience financials insights
Gather financial insights about Cadence Neuroscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$15M
2023
Series B
$26M
Cadence Neuroscience Tech Stack
A closer look at the technologies used by Cadence Neuroscience
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Funding
a medtech company specializing in early-stage the treatment of epilepsy and other neurological disorders, has secured $15 million in Series A funding. The round was led by Jazz Venture Partners, with participation from Mayo Clinical Ventures, Mayo Benefactors Innovation Fund, and the Epilepsy Foundation of America.
Funding
Executive Move
Executive Moves, Board of Directors
Cadence Neuroscience News & Media
Cadence Neuroscience Secures $26 Million in Series B Financing for Clinical Trials of Epilepsy Neuromodulation Therapy
REDMOND, Wash., May 17, 2023 /PRNewswire/ -- Cadence Neuroscience announced today that it has secured $26 million in Series B financing. The round was led by Angelini Lumira Biosciences Fund (co-managed by Lumira Ventures and Angelini Ventures) and included other new investors F-Prime...Cadence Neuroscience Raises $15M in Series A Financing
Cadence Neuroscience, a Redmond, Wash.-based developer of a novel neuromodulation therapy, secured $15m in Series A financing. The round was led by Jazz Venture Partners, with participation from Mayo Clinical Ventures, Mayo Benefactors Innovation Fund, and the Epilepsy Foundation of America (EFA). In conjunction with the funding, John F. Harris and Andrew Firlik, M.D., of […] The post Cadence Neuroscience Raises $15M in Series A Financing appeared first on FinSMEs.Cadence Neuroscience Secures $15 Million in Series A Financing for Commercialization of Epilepsy Therapy Licensed from Mayo Clinic
REDMOND, Wash., Nov. 6, 2019 /PRNewswire/ -- Cadence Neuroscience announced today that it has secured $15 million in Series A financing. The round was led by JAZZ Venture Partners, with additional support being provided by Mayo Clinical Ventures, Mayo Benefactors Innovation Fund, and the...Cadence Neuroscience Secures $15M in Series A
REDMOND, WA, Cadence Neuroscience announced today that it has secured $15 million in Series A financing led by JAZZ Venture Partners.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cadence Neuroscience
Sign Up For FreeTo access detailed company insights
Cadence Neuroscience develops new medical device therapies for the treatment of epilepsy and other neurological disorders. The company was founded in 2017 and is headquartered in Redmond, Washington.... Read More
